Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
| Class:Id | LiteratureReference:9858462 |
| _displayName | BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition |
| _timestamp | 2024-01-13 02:55:25 |
| author | [Person:9824573] Haq, Rizwan [Person:9732014] Yokoyama, Satoru [Person:9858455] Hawryluk, Elena B [Person:9858452] Jönsson, Göran B [Person:9858453] Frederick, Dennie Tompers [Person:9858454] McHenry, Kevin [Person:9858458] Porter, Dale [Person:9858461] Tran, Thanh-Nga [Person:9858460] Love, Kevin T [Person:9733411] Langer, Robert [Person:9733432] Anderson, Daniel G [Person:6798868] Garraway, Levi A [Person:9858457] Duncan, Lyn McDivitt [Person:9858451] Morton, Donald L [Person:9858459] Hoon, Dave S B [Person:6799030] Wargo, Jennifer A [Person:9839978] Song, Jun S [Person:3232166] Fisher, David E |
| created | [InstanceEdit:9858456] Rothfels, Karen, 2024-01-13 |
| journal | Proc Natl Acad Sci U S A |
| pages | 4321-6 |
| pubMedIdentifier | 23447565 |
| title | BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition |
| volume | 110 |
| year | 2013 |
| (literatureReference) | [RegulationReference:9858572] Positive gene expression regulation by 'MITF-M dimer:BCL2A1 gene [nucleoplasm]' BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition [Reaction:9858559] MITF-M dimer binds the BCL2A1 gene [Homo sapiens] [BlackBoxEvent:9858571] MITF-M-dependent BCL2A1 gene expression [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition (9858462)